NASA’s SpaceX 33rd commercial resupply mission will deliver a range of experiments to the International Space Station, including 3D bioprinting of implantable medical devices, studying the behavior of engineered liver tissues, examining microgravity’s effects on bone-forming cells, and additional 3D metal printing in space.

The SpaceX Dragon spacecraft is scheduled to launch in late August.

For nearly 25 years, the ISS has enabled scientists from over 110 countries to conduct more than 4,000 experiments in microgravity, advancing both fundamental science and space technology, Mirage News has reported.

Research aboard the station supports future missions to the Moon and Mars while also providing benefits for healthcare, materials science, and other applications on Earth.